NeuroFrontiers
Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.
So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.
1-15 of 381
Supporting Students with ADHD and Learning Differences
NeuroFrontiersSupporting Students with ADHD and Learning Differences
Roberto Olivardia, PhD
Untangling ADHD and Co-Occurring Conditions
NeuroFrontiersUntangling ADHD and Co-Occurring Conditions
Roberto Olivardia, PhD
Treating ADHD in the Presence of Comorbidities
NeuroFrontiersTreating ADHD in the Presence of Comorbidities
Roberto Olivardia, PhD
Roberto Olivardia, PhD
Long-Term ADHD Treatment: Examining Stimulant Tolerance
NeuroFrontiersLong-Term ADHD Treatment: Examining Stimulant Tolerance
James Swanson, PhD
James Swanson, PhD
- advertisement
Michael Levy, MD, PhD
Peter V. Sguigna, MD
Multidisciplinary Coordination in TK2d Diagnosis and Management
NeuroFrontiersMultidisciplinary Coordination in TK2d Diagnosis and Management
Charles Turck, PharmD, BCPS, BCCCP
Zarazuela Zolkipli-Cunningham, MBChB, MRCP
Oscar H. (Hank) Mayer, MD
Shradha Kakde, MBBS
Understanding Disparities in Migraine Diagnosis: Evidence from Real-World Data
NeuroFrontiersUnderstanding Disparities in Migraine Diagnosis: Evidence from Real-World Data
Juliana VanderPluym, MD
Vagus Nerve Stimulation Shows Short-Term Benefit in Chronic Migraine Trial
NeuroFrontiersVagus Nerve Stimulation Shows Short-Term Benefit in Chronic Migraine Trial
Rethinking Vestibular Migraine in Clinical Practice
NeuroFrontiersRethinking Vestibular Migraine in Clinical Practice
- advertisement
Improving Migraine Diagnosis in Vulnerable Populations
NeuroFrontiersImproving Migraine Diagnosis in Vulnerable Populations
Juliana VanderPluym, MD
Exploring the Role of IgG Autoantibodies in Idiopathic Inflammatory Myopathies (IIM)
Medical Industry FeatureExploring the Role of IgG Autoantibodies in Idiopathic Inflammatory Myopathies (IIM)
Brian P. McDonough, MD, FAAFP
Julie Paik, MD, MHS
The Role of CGRPs in First-Line Preventive Migraine Therapy
NeuroFrontiersThe Role of CGRPs in First-Line Preventive Migraine Therapy
Charles Turck, PharmD, BCPS, BCCCP
Richard B. Lipton, MD
Hope O'Brien, MD, MBA, FAHS, FAAN
